妓院一钑片免看黄大片,亚洲av无码成人精品国产,亚洲AV综合色区无码专区桃色,免费A级毛片在线播放不收费

美國領先仿生有限公司（Advanced Bionics）   
2009年11月9日美國唯一生產人工耳蝸的專業公司美國領先仿生有限公司（Advanced Bionics）宣布和瑞士Sonova集團達成并購協議。
美國領先仿生有限公司（Advanced Bionics）是全球領先的從事人工耳蝸的研發生產和技術創新的專業公司，公司的總部位于美國加州洛杉磯生物科學園。 　　
　　上個世紀80年代，加利福尼亞大學的舊金山分校的科學家獨立開發出了新型號的多通道人工耳蝸，Alfred E.Mann先生和該校洽談后獲得該技術，于1993年出資創建了美國領先仿生公司。

　　作為人工耳蝸領域的創新者，秉持“病人至上、品質第一”的服務宗旨，依托美國領先的電子技術和全球范圍內的研究中心，美國領先仿生有限公司擁有的最多的人工耳蝸注冊專利技術，我們以其強大的技術實力和銳意創新能力，成為該領域無可爭議的領導者。

我們的領先歷史： 我們的使命：

第一個提供設計多個程序存儲空間的聲音處理器。
第一個提供音量和靈敏度控制。
第一個提供環抱耳蝸軸的電極陣列。
第一個提供可充電電池技術。
第一個提供不同聲音處理策略的選擇能力。
第一個提供自然的麥克風位置。
第一個，并且是唯一的提供多個電極同時刺激。
第一個，并且是唯一的提供高分辨率聲音策略。
第一個能夠引發神經隨機響應的正常聽覺反應方式。
第一個提供通道定向技術。
第一個提供120個通道。
第一個同Phonak SmartLink藍牙系統兼容
......
　　創新和研發可植入的仿生技術使得患神經疾病的人們能克服自身的障礙，改善他們的生活，使聾者復聰、盲者復明、跛者復行！


執行總裁Jeff Grainer這樣描述公司：
　　“我們正在努力建立這樣一個公司，在這里，產品可靠性是最永遠放在第一位的，創新開發和進入市場的時間是我們成功的關鍵，任何想象豐富的念頭都受到鼓勵，紀律和團隊工作是我們的組織成分，我們的員工懂得一起投身于一項有意義的事業，他們工作的使命就是：改善他人的生活！” 
        
Advanced Bionics? Corporation is a global leader in developing the most reliable, best performing cochlear implant devices in the world. Founded in 1993, AB is the only American company developing cutting-edge cochlear implant technology that restores hearing to the deaf and allows our recipients to hear their best today, tomorrow, and always. We support patients, clinicians, and physicians through the latest scientific research, technology development, educational resources, attentive customer service, community involvement, and more.

AB evolved from two highly successful companies that developed and marketed innovative medical devices; one created new generation pacemakers, and the other developed microinfusion systems (miniature drug delivery pumps used in the treatment of diabetes). Our talented group of technologists and professionals from all over the world are driven to succeed, work with integrity, and stay firmly committed to quality.

Today, AB remains dedicated to improving lives by developing, manufacturing, and distributing the world’s most reliable, best performing cochlear implant system.

Our Mission
At AB, our mission is to improve lives by developing, manufacturing, marketing, and supporting high-quality, state-of-the-art hearing technology for those with severe to profound hearing loss.

Our commitment to providing the best possible hearing experience for our recipients by putting patients first remains at the forefront of all that we do. The trust our recipients place in us is the highest honor and inspires us to strive for excellence each and every day.

Our Culture
Our culture is best described by our people: highly intelligent, spirited, ambitious, and dedicated. We attract innovative technologists and distinguished professionals from all over the world who are committed to improving the lives of those with severe to profound hearing loss.

The culture of AB is shaped daily by our unique mission, the leaders who successfully drive the business, and the staff members from all across the globe who help our recipients hear their best.

"We are building a company with a culture where reliability matters most, where innovation and time to market are the keys to our financial success, where crazy ideas are encouraged, where discipline and teamwork are part of our fabric, and where our employees understand the privilege of being engaged together in a business whose mission is to improve the lives of others."

—Jeff Greiner, President and Co-Chief Executive Officer

Our Focus
At AB, we focus on putting patients first in everything that we do. As part of our firm commitment to patients, we’ve enacted eight core initiatives, each designed to improve the lives of our recipients on their journey to hearing with AB.

Reliability: Deliver reliable cochlear implant systems.
Improvements: Make improvements on ease of use and aesthetics of our cochlear implant systems.
Communicate Differences: Communicate the performance differences between devices.
Make It Easy: Make it easy for patients and clinicians to get what they need.
Reimbursement: Help patients and clinicians access appropriate insurance reimbursement.
Legacy Patients: Support legacy patients throughout their journey to hearing.
Global Company: Address the needs of our patients across the world.
Lifelong Partner: Remain reasonably profitable in order to be a lifelong partner to our recipients.
Leadership
Jeff Greiner
President and Chief Executive Officer
A lawyer by training and an Air Force Academy graduate, Jeff Greiner has been the operational leader of Advanced Bionics? from its beginning.

He served a commitment to the Air Force as part of the Judge Advocate General’s Department. He left the Air Force in 1986 and became the Associate General Counsel for Siemens-Pacesetter and the Acting General Counsel for MiniMed Technologies, Limited, the predecessor entity which produced both MiniMed, Inc. and Advanced Bionics Corporation.

In 1992, Mr. Greiner left Siemens-Pacesetter to lead and build AB into a leading neurological device company. He has grown the company from seven employees in 1992 to over 600 employees in 2009 with an emphasis on leadership and the creation of an innovative and spirited culture, where creativity and discipline are the keys to producing exceptional technology that improves lives.

He holds a B.S. degree in Economics with highest honors from the United States Air Force Academy (1974), a JD degree from UCLA (1977), and an LLM with highest honors from George Washington University (1985).

Al Mann
Chairman and Founder
Alfred E. Mann serves as Chairman of the Board and CEO of MannKind Corporation, a diversified biopharmaceutical company focused on the development of novel therapeutics and drug-delivery technologies for the treatment of diabetes, cancer, autoimmune, and inflammatory diseases. MannKind’s lead product mimics the insulin kinetics of a normal pancreas, creating a new therapy paradigm for diabetes. In 1993, Mr. Mann also founded and began serving as Chairman and co-CEO of Advanced Bionics Corporation (“"Bionics”).

Additionally, Mr. Mann founded and served as the Chairman of the Board and Chief Executive Officer of MiniMed, Inc. from its founding in 1993 until August 2001 when it was